Navigation Links
Amikacin Inhale Shows Promising Results in Phase II Study
Date:5/19/2008

ection, without reaching high systemic concentrations."

Amikacin Inhale is a unique drug-device combination, being developed by Bayer HealthCare in cooperation with Nektar Therapeutics, combining a special liquid formulation of the aminoglycoside antibiotic amikacin with Nektar Therapeutics' proprietary Liquid Pulmonary Technology (LPT(TM)), designed to deliver amikacin deep into the infected lungs.

The device can be integrated into mechanical ventilation systems and can also be used as a handheld 'off-vent' device for patients no longer requiring breathing assistance. This allows for a unique full course of drug therapy in critically ill patients with Gram-negative pneumonia. 'Gram-negative pneumonia' refers to pneumonia caused by a laboratory-defined group of pathogens, the Gram-negative bacteria. These account for a substantial proportion, if not the majority of pneumonias in intensive care units (ICUs).

"A challenge in treating Gram-negative pneumonia in ICUs is that they have grown increasingly resistant to currently available antibiotics," said Professor Donald Low, Head of the Department of Microbiology at the Toronto Medical Laboratories and Mount Sinai Hospital, Toronto, Canada. "A new treatment option such as Amikacin Inhale, which fights pneumonia directly at the site of infection, may be able to help decrease resistance -- especially if concomitant intravenous antibiotic therapy can also be reduced."

Amikacin Inhale will enter Phase III trials later this year to further assess its efficacy and safety in mechanically ventilated patients with Gram-negative pneumonia. The enrolment for two pivotal Phase III studies will start in the fourth quarter of 2008.

About Phase II Studies

High Amikacin Lung Deposition in MVP(2)

In the multi-center, randomized, double-blind, placebo-controlled Phase II study mechanically ventilated patients (MVP) received 400 mg doses of amikacin with Amikacin Inhale every 24 hours (n=2
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
2. Inhaled Steriods Used as Preventive Treatment Post 9/11
3. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
4. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
7. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
8. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
11. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The clinical and ... be the difference between a product,s success or failure. ... and stratify KOL targets – and then to coordinate ... of strong relationships upon which successful KOL engagement rests. ... companies have identified internal inconsistencies in their KOL management ...
(Date:8/29/2014)... WILSONVILLE, Ore. , Aug. 29, 2014 /PRNewswire-iReach/ ... its Accessory (Axilla) Strap for the SAM Junctional ... SAM Medical Products announced ... a voluntary recall to address a potential issue ... strap used for the Axilla application of the ...
(Date:8/29/2014)...  A Boston Scientific Corporation (NYSE: ... and preliminary long term stricture resolution of benign ... issue of the peer-reviewed journal, Gastroenterology. ... conducted in 11 countries and five continents, and ... (FCSEMS) after extended indwell (i.e., up to 12 ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... JERUSALEM , June 2, 2010 Oramed ... announced,today that its subsidiary Oramed Ltd. entered into a joint ... company listed on,the Tel Aviv Stock Exchange, for the establishment ... Under the terms of the agreement, Oramed,will out-license technology to ...
... June 1 The U.S. Food and Drug Administration today approved Prolia, ... for fractures. , , , ... ) , , , ... which the bones become weak and are more likely to break. According to ...
Cached Medicine Technology:Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 2Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 3FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women 2FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women 3
(Date:8/29/2014)... A recent article discusses the creation ... clothing store for men with gynecomastia, or male breasts, to ... their problem. Board-certified plastic surgeon Dr. Chasan is familiar with ... people only associate male breasts with men who are excessively ... of all ages, often starting in adolescence. Men with the ...
(Date:8/29/2014)... Pursuing its deepest desires to help ... a stunning new design that promises to redefine the ... notable surrogacy platform has witnessed a 42 percent increase ... a month, the FindSurrogateMother.com community is formed by hopeful ... goal — the precious gift of life. , Whether ...
(Date:8/29/2014)... report released yesterday by the Mental Health Commission ... health training and education that police personnel receive. ... issue for Canada,s police community, and today,s report ... enforcement and people with mental illnesses," says Queen,s ... an interest in the area of police psychology. ...
(Date:8/29/2014)... D.C. (PRWEB) August 29, 2014 Today, ... Community Anti-Drug Coalitions of America (CADCA) , the nation’s ... in response to President Obama’s intent to nominate Michael ... , “CADCA strongly supports President Obama’s decision to nominate ... is the ideal person to hold this important position ...
(Date:8/29/2014)... August 29, 2014 Thirteen Novant ... prestigious Great 100 Nurses in North Carolina ... nursing excellence and provides scholarships to nursing students at ... from Novant Health Presbyterian Medical Center are: ... Kelley, Nora King, Lissa Ready, Amber Segerlin, Carmen Smith, ...
Breaking Medicine News(10 mins):Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Report advocates improved police training 2Health News:CADCA Statement on Nomination of Michael Botticelli as U.S. Drug Czar 2Health News:Great 100 Honors 13 Novant Health Nurses 2
... Prevention efforts ,have run out of steam, expert says, , , ... risk of dying prematurely? Don,t smoke and keep a healthy ... about one in five deaths among U.S. adults, according to ... to be linked with premature death, the magnitude of the ...
... East and the Asia-Pacific region , , TUESDAY, April 28 (HealthDay ... in the United States has doubled to 40, U.S. health ... a New York City high school that had previously reported ... Tuesday were listing the number of U.S. cases at 50, ...
... Trends Suggest These Agents Will Face Greater Use of ... on Commercial Health Plans, According to a New Report ... N.J., April 28 HealthLeaders-InterStudy and Fingertip ... antihypertensives are expected to face tougher formulary restrictions. According ...
... Doors with Offices in New York ... 28 Diversified Agency Services (DAS) today announced the launch ... New York and London. TogoRun specializes in healthcare, pharmaceutical ... roster includes many of the world,s leading healthcare brands.The new ...
... by Troops Coming Home from WarCAMBRIDGE, Mass., April 28 ... Veterans Affairs Appropriations Subcommittee on behalf of ALS patients, ... (ALS TDI), last Thursday. Dr. Appel urged congress ... such as the one at ALS TDI. Dr. ...
... 28 Verathon(R) is pleased to announce the new ... with Urologists in mind, the BVM 9500 measures both ... noninvasively to help diagnose bladder dysfunction, including BPH (benign ... new addition to the BladderScan(R) BVI 9000 series made ...
Cached Medicine News:Health News:1 in 5 U.S. Deaths Attributed to Smoking, High BP 2Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 2Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 3Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 4Health News:Some Reports Put Number of U.S. Swine Flu Cases at 50 5Health News:Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions 2Health News:Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions 3Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 2Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 3Health News:Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency 4Health News:ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs 2Health News:ALS Therapy Development Institute Delivers Impassioned Testimony to Congressional Subcommittee on Veterans Affairs 3Health News:Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction 2Health News:Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: